transgene-free genome editing in plants using a miniature CRISPR system delivered by a common plant virus. Collaborating with CRISPR-Cas9 co-inventor Jennifer Doudna and Jill Banfield at UC Berkeley, ...

A U.S. company develops a trait that it says provides genetic resistance to sclerotinia, which can be challenging for growers ...

The research team demonstrated the successful knockout of the BnaMS1 and BnaMS2 genes in elite rapeseed lines using CRISPR/Cas9, producing stable male-sterile plants that retained normal female ...

CRISPR Therapeutics stock is heavily shorted in the weeks going into earnings The short-sellers are betting against the name in a big way, with more than 20 million shares sold short as of the ...

Gene therapy stocks like CRISPR Therapeutics and Intellia Therapeutics are facing significant volatility in 2025, influenced by market instability and regulatory uncertainties. CRSP is better ...

This makes it possible to specifically modify a targeted gene in plant, animal and human cells. Ultimately, CRISPR became a preferred method in the search for treatments for acquired or hereditary ...

Importantly, the genome changes can be passed on to future generations and the novel system doesn't leave behind the virus or any foreign DNA in the edited plant. "CRISPR has the potential to make ...